Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
Improving the Bioavailability of your Compound
Many APIs have poor physicochemical properties that may struggle to get sufficient exposure when dosed to patients. We can develop a variety of formulations that potentially offer improvements in the bioavailability of your compound.
Through our advanced techniques, we can offer:
- Micronisation of API
- Spray dried amorphous material (aqueous & solvent capabilities)
- Solubilised / lipid-based systems
Never limiting ourselves to the technologies we have available in-house, we are happy to accommodate your particular approach or platform technology and will work with external parties.
To tackle the bioavailability challenges of your compound, our knowledgeable scientists will assess different formulations by developing discriminatory dissolution methods and by arranging comparative bioavailability studies. With their expertise, they can also devise a practical way to take one of these approaches forward to GMP manufacture.